Genomes from 240 mammalian species revealed what makes the human genome unique
On Apr. 27, 2023, the Zoonomia Project team announced in in a special issue of Science, that had…
U.S. state-by-state analysis of COVID-19 impact revealed driving forces behind variations in health published in The Lancet
On Apr. 23, 2023, the most comprehensive state-by-state analysis of the impacts of COVID-19 across the USA, published…
AI system generated novel proteins that meet structural design targets
On Apr. 20, 2023, Massachusetts Institute of Technology (MIT) researchers announced that have developed machine-learning algorithms that can…
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics
U.S. Preventive Services Task Force issued recommendation on screening for skin cancer
On Apr. 18, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
Biotechnology | CRISPR | Diagnostics | Disease | Genomics | Therapeutics
Jennifer Doudna and Jill Banfield to lead $70 million initiative to edit the microbiome
On Apr. 17, 2023, a new initiative led by Jennifer Doudna and Jill Banfield at the Innovative Genomics…
U.S. FDA Approved First Therapeutic Indication for Revance’s DAXXIFY® (DaxibotulinumtoxinA-lanm) for the Treatment of Cervical Dystonia
On Apr. 14, 2023, Revance Therapeutics announced that the U.S. Food and Drug Administration (FDA) had approved the…
Parkinson’s disease biomarker found
On Apr. 13, 2023, in an enormous leap forward in the understanding of Parkinson’s disease (PD), researchers announced…
U.S. spending $5 billion to speed up development of new COVID vaccines
On Apr. 10, 2023, the U.S. Department of Health and Human Services (HHS) announced it was spending over…
Gene therapy allowed teen to see snowflakes for the first time
On Apr. 5, 2023, researchers at Oregon Health & Science University’s OHSU Casey Eye Institute announced that gene…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Therapeutics | Vaccine
Frequent testing reduced COVID-19 deaths in nursing facilities
On Apr. 4, 2023, National Institutes of Health (NIH) funded research was announced from the University of Rochester…
U.S. FDA approved first Over-the-Counter Naloxone nasal spray
On Mar. 29, 2023, the U.S. Food and Drug Administration (FDA) announced approval of Narcan, 4 milligram naloxone…
Hutchinson Cancer Center announced new “patient-centric” building in South Lake Union
On Mar. 23, 2023, the Fred Hutchinson Cancer Center (FHCRC) announced a new building in South Lake Union…
Vaccine makers prep bird flu shot for humans ‘just in case’; rich nations lock in supplies
On Mar. 20, 2023, some of the world’s leading makers of flu vaccines said they could make hundreds…
Federal investment to increase Canada’s capacity to develop and manufacture critical medicines
On Mar. 17, 2023, PrairiesCan announced $80,514,000 over five years to support the Canadian Critical Drug Initiative and…
FDA Advisory Committee voted in support of favorable benefit-risk profile for Pfizer’s PAXLOVID
On Mar. 16, 2023, Pfizer announced that the U.S. Food and Drug Administration’s Antimicrobial Drugs Advisory Committee (AMDAC)…
Texas A&M scientists disable protective gene In mosquitoes
On Mar. 15, 2023, scientists at Texas A&M announced that a research study: ‘RNA interference is essential to…
‘Deaths of Despair’ contributed to 17% rise in Minnesota’s death rate during COVID-19 pandemic
On Mar. 13, 2023, Mayo Clinic published a study that showed the COVID-19 pandemic was linked to a…
Pfizer announced acquisition of Seattle-based Seagen for $43 billion
On Mar. 13, 2023, Pfizer announced an agreement to acquire Seagen, a global biotechnology company that discovers, develops…
Pfizer’s ZAVZPRET (zavegepant) Migraine Nasal Spray received FDA approval
On Mar. 10, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ZAVZPRET (zavegepant),…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics | Women's Health
FDA updated mammography regulations to require reporting of breast density information and facility oversight
On Mar. 9, 2023, the U.S. Food and Drug Administration (FDA) announced that it had published updates to…
Amphastar Pharmaceuticals received FDA approval for Naloxone hydrochloride nasal spray
On Mar. 8, 2023, Amphastar Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had granted approval…
Outbreak of Blastomycosis reported in Michigan Mill workers
On Feb. 28, 2023, Public Health Delta & Menominee Counties (PHDM) was alerted to three cases of atypical…
Higher-Dose and longer duration of Ivermectin not effective with COVID-19
On Feb. 20, 2023, results from a randomized clinical trial of Ivermectin in a higher-hose and longer duration…
CPRIT approved $12 million to bring top-flight cancer researchers to Lone Star State
On Feb. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced a major step forward…
Researchers document third known case of HIV remission involving stem cell transplant
On Feb. 15, 2023, it was reported that a 53-year-old man in Germany had become at least the…
British Columbia Institute of Technology received $14.5 million to support aerospace and life sciences training
On Feb. 14, 2023, the Pacific Economic Development Agency of Canada (PacifiCan), announced $14.5 million in funding for…
Large-scale genetic analysis showed microRNAs in human pancreas associated with diabetes
On Feb. 9, 2023, the National Institutes of Health (NIH) announced that a new large-scale genetic analysis found…
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics | WHO | Women's Health
WHO launched new roadmap on breast cancer
On Feb. 3, 2023, the World Health Organization (WHO) released an updated Global Breast Cancer Initiative (GBCI) Framework…
Biotechnology | Disease | NIH | Therapeutics | Vaccine
Experimental NIH Sudan virus vaccine protected Macaques
On Feb. 2, 2023, a National Institutes of Health research group with extensive experience studying ebolavirus countermeasures successfully…
A 19-Year-Old Adolescent with Probable Alzheimer’s Disease
On Jan. 31, 2023, a team of researchers led by the Innovation Center for Neurological Disorders and Department…